iGUIDE
iGUIDE refines detection and quantification of on-target and off-target CRISPR-Cas9 cleavage sites and characterizes associated deletions to improve cleavage specificity analysis.
Key Features:
- Mispriming Event Filtering: Implements algorithmic filtering to remove mispriming-derived noise that can obscure true double-strand break (DSB) signals.
- Comprehensive Cleavage Site Mapping: Precisely specifies genomic locations of Cas9-guided cleavages across multiple guide RNAs.
- Deletion Characterization: Identifies and characterizes deletions associated with CRISPR-induced cleavage events.
- Background DSB Association Analysis: Associates naturally occurring background DSBs with genomic features such as open chromatin, high gene density, and chromosomal fragile sites.
Scientific Applications:
- Off-target assessment in genome editing: Enables accurate mapping and quantification of CRISPR-Cas9 off-target cleavage sites for evaluating editing specificity.
- Characterization of induced genomic alterations: Supports analysis of deletions and other sequence alterations resulting from CRISPR activity.
- Distinguishing CRISPR-induced versus natural DSBs: Facilitates separation of nuclease-induced breaks from background DSBs by relating breaks to chromatin state and genomic context.
Methodology:
Computational pipeline that improves upon GUIDE-seq by incorporating algorithms to filter mispriming noise and thereby refine detection, quantification, and deletion characterization of CRISPR-Cas9 cleavage sites.
Topics
Details
- License:
- GPL-3.0
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 5/25/2019
- Last Updated:
- 6/16/2020
Operations
Publications
Nobles CL, Reddy S, Salas-McKee J, Liu X, June CH, Melenhorst JJ, Davis MM, Zhao Y, Bushman FD. iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity. Genome Biology. 2019;20(1). doi:10.1186/s13059-019-1625-3. PMID:30654827. PMCID:PMC6337799.
PMID: 30654827
PMCID: PMC6337799
Funding: - National Institute of Allergy and Infectious Diseases: AI 045008, AI 08020, AI 117950, AI 126620, P30 Ai 045008